Hospitalisation and mortality from COVID-19 in Mexican indigenous people: a cross-sectional observational studyObservational Study Published on 2022-01-012022-10-05 Journal: Journal of epidemiology and community health [Category] SARS, 임상, [키워드] 95% CI adjusted being Care Characteristics Clinical practice COVID-19 cross-sectional death Deprivation diabetes effort Ethnic groups Health healthcare higher odd higher risk hospital equipment hospitalisation hospitalised hypertension individuals inequalities laboratory-confirmed male Ministry of Health MoH morbidity Mortality obesity Older outcome outcomes Patient patients patients with COVID-19 Probability PROTECT resource SARS-CoV-2 SARS-COV-2 infection Sociodemographic used data Variation with COVID-19 [DOI] 10.1136/jech-2020-216129 PMC 바로가기 [Article Type] Observational Study
Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trialRandomized Controlled Trial Published on 2022-01-012022-10-05 Journal: Lancet (London, England) [Category] 임상, [키워드] 1:1 95% CI allergic reaction Analysis anticoagulation assigned Asymptomatic Bayer blinded Brazil carried Clinical outcome conducted Controlled trial COVID-19 D-dimer D-dimer level death discharged Efficacy elevated eligibility enrolled FIVE Follow-up high risk hospital discharge hospitalisation hospitalised increased risk intensive care intention-to-treat intention-to-treat analysis intention-to-treat population major bleeding multicentre occurred Open-label outcome Patient patients prevention primary analysis randomised Randomised trial Randomly receive Registered registry risk rivaroxaban screened Standard dose study group symptomatic Thromboembolism Thromboprophylaxis thrombotic event Trial Two patient venous Venous Thromboembolism with COVID-19 withdrawal of consent [DOI] 10.1016/S0140-6736(21)02392-8 PMC 바로가기 [Article Type] Randomized Controlled Trial
COVID-19 hospital prevalence as a risk factor for mortality: an observational study of a multistate cohort of 62 hospitalsObservational Study Published on 2022-01-012022-10-05 Journal: BMJ Quality & Safety [Category] SARS, 임상, [키워드] 95% CI accounted adjusted Admission analysed AOR averaged Care Clinical risk factors Cohort COVID-19 COVID-19 mortality COVID-19 patient death declined evaluated health system hospital hospital medicine hospitalised increase in linear mixed model Mortality mortality (standardised mortality ratios). multivariable analysis pandemic Patient patients with COVID-19 Prevalence prevalence of COVID-19 Probability random effect remained risk factor SARS-COV-2 infection Support Volume with COVID-19 [DOI] 10.1136/bmjqs-2021-013721 PMC 바로가기 [Article Type] Observational Study
Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy2 차 항체 결핍 환자의 지속적인 SARS-COV-2 감염 : Casirivimab 및 Imdevimab (Regn-Cov2) 모노클로 날 항체 요법에 따른 성공적인 통관Case Reports Published on 2021-12-302022-09-01 Journal: Annals of Clinical Microbiology and Antimicrobials [Category] SARS, 변종, 진단, 치료기술, [키워드] accompanied administration antibody Antibody deficiency Antibody Response Antibody responses antiviral therapy B cell B cell depleting therapy benefit Case report case reports Casirivimab Chronic COVID-19 Chronic lymphocytic leukaemia clearance Clinical improvement clinical recovery clinical response clinical study Clinical use Combination convalescent plasma deficiency delivery depleting ecological ecological niche Effectiveness evade Evidence Evolution failure fatigue female follicular Follicular lymphoma Formal highlight hospitalised Ibrutinib Imdevimab immune evasion Immunotherapy increased risk individuals Infection Inflammation lack lymphoma malaise male monoclonal antibody monoclonal antibody combination nasopharyngeal swabs neutralisation omicron outcome Passive immunisation Patient patients persistent persistent infection Primary and secondary immunodeficiency raised REGN-CoV2 Remdesivir Ronapreve (REGN-COV2) SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant SARS-CoV-2 variants secondary antibody secure Sequence analysis spike variant suffered sustained therapeutic therapy treated Treatment variants variants of concern Viral viral clearance viral evolution virological clearance with COVID-19 withdrawn [DOI] 10.1186/s12941-021-00491-2 PMC 바로가기 [Article Type] Case Reports
Determinants of severity among hospitalised COVID-19 patients: Hospital-based case-control study, India, 2020Research Article Published on 2021-12-292022-10-28 Journal: PLoS ONE [Category] COVID-19, SARS, [키워드] Admission age C-reactive protein case control study case-control study characterising Chronic kidney disease Clinical management Clinical Management Protocol conducted COVID-19 COVID-19 disease Critical death Degradation determinant early stage Factor finding help high risk hospital hospitalised identify India interleukin-6 lactate dehydrogenase Liver function Mortality nine NLR outcome parameter Patient pro-calcitonin Prothrombin time renal function reported serum electrolyte Serum ferritin severe COVID-19 severe COVID-19 disease severe disease severity [DOI] 10.1371/journal.pone.0261529 PMC 바로가기 [Article Type] Research Article
Burden of nosocomial COVID-19 in Wales: results from a multicentre retrospective observational study of 2508 hospitalised adultsBrief Communication Published on 2021-12-222022-10-28 Journal: Thorax [Category] COVID-19, SARS, [키워드] Admission burden clinical epidemiology Community COVID-19 defined Diagnosis hospitalised hospitals Infection infection control Inpatient IQR Measures median Mortality multicentre nosocomial nosocomial COVID-19 Nosocomial infection occurred Older outcome participant Prophylactic ranged representing respiratory infection retrospective SARS-CoV-2 SARS-COV-2 infection viral infection [DOI] 10.1136/thoraxjnl-2021-216964 PMC 바로가기 [Article Type] Brief Communication
Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort studyObservational Study Published on 2021-12-222022-10-04 Journal: BMJ Open [Category] Fulltext, SARS, 임상, [키워드] 95% CI acute respiratory distress adverse event adverse outcome arrhythmia Cohort cohort study Comorbidity COVID-19 COVID-19 patient database death diabetes diagnosed diagnosed with COVID-19 disease dyslipidaemia Epidemiology Europe female had more healthcare hospitalisation hospitalised hospitalised patient hypertension increased mortality individual Inpatient National obesity objective outcome outcomes outpatients participant partnership Patient patients with COVID-19 prevalent reported Result retrospective cohort study South Korea stratified study period syndrome USA with COVID-19 [DOI] 10.1136/bmjopen-2021-057632 PMC 바로가기 [Article Type] Observational Study
Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 20212021년 11월부터 12월까지 노르웨이에서 SARS-CoV-2 Omicron 변종으로 인한 발병Rapid Communication Published on 2021-12-162022-09-10 Journal: Eurosurveillance [Category] SARS, 변종, 치료기술, [키워드] attack rate caused Christma cohort-study COVID-19 Delta effective hospitalised less MOST Norway omicron Omicron variant outbreak Outbreak investigation participant preventing infection SARS-CoV-2 Symptoms the SARS-CoV-2 vaccination variant [DOI] 10.2807/1560-7917.ES.2021.26.50.2101147 PMC 바로가기 [Article Type] Rapid Communication
Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 20212021년 12월 덴마크에서 발생한 최초의 785 SARS-CoV-2 Omicron 변종 사례의 역학적 특성 분석Rapid Communication Published on 2021-12-162022-09-10 Journal: Eurosurveillance [Category] SARS, 변종, [키워드] booster can not characterisation community transmission COVID-19 death Denmark Epidemiology FIVE hospitalised information intensive care Laboratory majority MOST omicron Registered reported symptom required SARS-CoV-2 SARS-COV-2 infection Surveillance variant viral infections were infected widespread [DOI] 10.2807/1560-7917.ES.2021.26.50.2101146 PMC 바로가기 [Article Type] Rapid Communication
COVID-19 trends and severity among symptomatic children aged 0–17 years in 10 European Union countries, 3 August 2020 to 3 October 2021Rapid Communication Published on 2021-12-162022-10-31 Journal: Eurosurveillance [Category] COVID-19, SARS, [키워드] adjusted odds ratio children Comorbidities Comorbidity country COVID-19 COVID-19 case died Europe European had no hospitalisation hospitalised Intensive intensive care outcome reported required risk severity Surveillance symptomatic Transmission union [DOI] 10.2807/1560-7917.ES.2021.26.50.2101098 PMC 바로가기 [Article Type] Rapid Communication